Astellas Pharma China, Inc.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 1994-10-14
- Employees
- -
- Market Cap
- -
- Website
- https://www.astellas.com.cn
A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects
Phase 1
Completed
- Conditions
- Pharmacokinetics of Tamsulosin HydrochlorideHealthy
- Interventions
- First Posted Date
- 2014-05-15
- Last Posted Date
- 2014-07-16
- Lead Sponsor
- Astellas Pharma China, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT02138773
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
- First Posted Date
- 2013-11-13
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Astellas Pharma China, Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT01982071
Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients
Phase 4
Completed
- Conditions
- End-organ DamageHypertension Emergency
- Interventions
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2015-11-16
- Lead Sponsor
- Astellas Pharma China, Inc.
- Target Recruit Count
- 163
- Registration Number
- NCT01872039
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Astellas Pharma China, Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT01745159
Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers
- First Posted Date
- 2012-11-02
- Last Posted Date
- 2012-11-02
- Lead Sponsor
- Astellas Pharma China, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01720212
© Copyright 2025. All Rights Reserved by MedPath